Nevro Corp.

NYSE NVRO

Nevro Corp. Current Liabilities for the quarter ending September 30, 2024: USD 95.41 M

Nevro Corp. Current Liabilities is USD 95.41 M for the quarter ending September 30, 2024, a 19.65% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Nevro Corp. Current Liabilities for the quarter ending September 30, 2023 was USD 79.74 M, a -0.69% change year over year.
Nevro Corp. Current Liabilities for the quarter ending September 30, 2022 was USD 80.30 M, a 7.28% change year over year.
Nevro Corp. Current Liabilities for the quarter ending September 30, 2021 was USD 74.85 M, a -68.74% change year over year.
Nevro Corp. Current Liabilities for the quarter ending September 30, 2020 was USD 239.43 M, a 250.42% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

NYSE: NVRO

Nevro Corp.

CEO	Mr. Kevin R. Thornal
IPO Date	Nov. 6, 2014
Location	United States
Headquarters	1800 Bridge Parkway
Employees	1,215
Sector	Health Care
Industries Pharmaceuticals Medical Instruments Virtual Reality (VR)

Description

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Key trends

Past 5 years